register

Digital & Innovation

Medical Observer moves to digital-only to meet rising demand

Health Industry Hub | September 17, 2019 |

Australian Doctor Group, the country’s number one healthcare media company, is moving its monthly masthead Medical Observer to digital-only next month to meet growing online demand.

The important milestone comes after rapid growth in popularity of the masthead’s digital offering following the launch of ADG’s new supersite AusDoc.PLUS five months ago.

Since April, the number of doctors reading Medical Observer online has increased 65%, with an additional 16,000 newsletters being sent out each month to subscribers.

As doctors increasingly shift online, Medical Observer, and ADG, are moving with them, says ADG Managing Director Bryn McGeever.

“This move allows us to continue to invest in our digital offering providing our readers with up-to-date news, opinion and education, anywhere, anytime and on any device,” says Mr McGeever.

The trusted opinion, analysis and in-depth clinical and practice features readers of Medical Observer magazine have come to expect will continue to be published daily on AusDoc.PLUS, alongside all the best brands in Australian medical media including Australian Doctor, How to Treat and 6minutes.


ESG

Surgeons lead push for $1.5 million hospital sustainability project

Surgeons lead push for $1.5 million hospital sustainability project

Health Industry Hub | October 23, 2024 |

ESG: Australia’s healthcare sector contributes 7% of the country’s total emissions. The Royal Australasian College of Surgeons (RACS) has joined […]

More


News & Trends - MedTech & Diagnostics

AI-assisted colonoscopy boosts polyp and adenoma detection

AI-assisted colonoscopy boosts polyp and adenoma detection

Health Industry Hub | October 23, 2024 |

MedTech & Diagnostics News: In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas can go by […]

More


News & Trends - Pharmaceuticals

'Every day of delay is costing Australian lives', says Rare Cancers Australia CEO

‘Every day of delay is costing Australian lives’, says Rare Cancers Australia CEO

Health Industry Hub | October 23, 2024 |

Pharma News: Rare Cancers Australia (RCA) has voiced its disappointment alongside the pharmaceutical industry following the Pharmaceutical Benefits Advisory Committee’s […]

More


News & Trends - Pharmaceuticals

Government's silence on Senate report leaves cancer patients in limbo

Government’s silence on Senate report leaves cancer patients in limbo

Health Industry Hub | October 23, 2024 |

Pharma News: NeuroEndocrine Cancer Australia has urged the government to respond to the Senate report on equitable access to diagnosis […]

More


This content is copyright protected. Please subscribe to gain access.